IP Watchdog

APRIL 3, 2023

The Information Technology and Innovation Foundation (ITIF) is hosting an event on the downfall of Japan’s pharmaceutical industry. This week in Washington IP news, Congress is out of town thanks to a state work period, but there are still several interesting events related to the IP world.

IP 59

IP Business Technology Government 59

JD Supra Law

NOVEMBER 23, 2022

???????After a recent reminder from the U.S. Patent and Trademark Office (USPTO) regarding the duties of disclosure and reasonable inquiry during examination of a patent application and a Request for Comments (RFC) on the USPTO initiatives to ensure “robustness and reliability” of patent rights, the Director of the U.S.

Patent 98

Patent Patent Application Publishing Trademark 98

JD Supra Law

OCTOBER 20, 2022

???????The new Director of the U.S. Patent and Trademark Office (USPTO), Katherine Vidal, published a stern reminder regarding the duties of disclosure and reasonable inquiry during examination of a patent application, including reexamination, reissue, and proceedings before the Patent Trial and Appeal Board (PTAB) (87 FR 45764 (July 29, 2022)).

Patent Application 52

Patent Application Publishing Trademark Patent 52

JD Supra Law

APRIL 9, 2024

In a recent petition to the Supreme Court, Vanda Pharmaceuticals, which is becoming one of the most aggressive litigators in the pharmaceutical industry, is now arguing that this standard is contrary. By: Axinn, Veltrop & Harkrider LLP

Art 111

Art Patent Law Litigation Law 111

JD Supra Law

AUGUST 1, 2022

President Biden’s Executive Order on Promoting Competition in the American Economy, 86 FR 36987 (2021), expressed concerns about the patent system being misused to unnecessarily inhibit or delay entry of generic drugs or biologics to the marketplace for years, denying Americans access to lower cost drugs.

Publishing 52

Publishing Patent 52

IIPRD

APRIL 2, 2024

[iii] Understanding the intricacies of the negotiations thus, becomes even more critical when we consider the actualities of the pharmaceutical industry. The implementation of TRIPS-Plus provisions can also readily facilitate the emergence of monopoly power for brand-name pharmaceutical companies. [v]

Intellectual Property 105

Intellectual Property Branding Brands Branding 105

Intepat

APRIL 23, 2024

This principle was firmly established by the Supreme Court of India in the landmark decision of Cadila Health Care Limited vs. Cadila Pharmaceuticals Limited (2001). In this case, the court highlighted the pivotal role of careful branding in the pharmaceutical Industry. In the case of Anafortan v.

Branding 52

Branding Brands Branding Trademark 52

Olartemoure Blog

SEPTEMBER 25, 2023

The collaboration between pharmaceutical chemists and lawyers specializing in intellectual propperty form an unstoppable team. The pharmaceutical industry is driven by innovation From discovering new compounds with therapeutic potential to developing novel drug delivery systems, pharmaceutical chemists play a pivotal role in this process.

IP 105

IP Intellectual Property Licensing Technology 105

JD Supra Law

JANUARY 9, 2024

An August 2023 decision from the Federal Circuit Court of Appeals highlighted potential new fragilities in the patent portfolios of many industry giants, especially those in the pharmaceutical industry. By: Womble Bond Dickinson

Patent 73

Patent 73

SpicyIP

FEBRUARY 7, 2022

We’re pleased to inform you that The British Institute of International and Comparative Law (BIICL) is offering a short course on ‘Pharmaceuticals and Intellectual Property’ from 4th March 4 to 13th May, 2022. Short course: Pharmaceuticals and Intellectual Property. What does the pharmaceutical industry patent?

Intellectual Property 98

Intellectual Property Law Government IP 98

JD Supra Law

FEBRUARY 12, 2024

Federal Trade Commission (FTC) took the next step in its long-standing effort to encourage lower prices and increase competition in the pharmaceutical industry.

Government 79

Government Technology 79

IP Law 360

FEBRUARY 13, 2024

A Delaware federal judge has dismissed 10 of the originally asserted 14 patents in pharmaceutical company Mallinckrodt's claims against a French industrial gas company over a generic version of its pediatric breathing disorder treatment, as Mallinckrodt filed an amended complaint adding two additional patents to the suit.

IP 69

IP Patent 69

JD Supra Law

MAY 23, 2023

As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the tech industry. Though not to an equal degree, the biotechnology, pharmaceutical, and life science industries have not been excluded from employment cuts.

Patent Application 98

Patent Application Patent 98

Corsearch

DECEMBER 7, 2023

As a space inundated with trademark complexities, regulatory issues, a saturated marketplace, intense counterfeiting issues, and much more, the pharmaceutical industry represents perhaps the most complex area of trademark law. Access webinar ✕ Access recording

Trademark 59

Trademark Trademark Law Reporting Branding 59

SpicyIP

MAY 17, 2023

The Special 301 Report is a unilateral measure whereby the identified countries, whose IP regimes are not in line with the trading interests of the US industries, are placed a threat of unilateral sanctions. With this background, we are pleased to bring to you a guest post by Prof. 56, para 3).

Reporting 137

Reporting Intellectual Property Patent Application Intellectual Property Law 137

Corsearch

NOVEMBER 20, 2023

For pharmaceutical companies, name confusion is a critical risk to consumers and patients. Name saturation is an existential challenge for every industry that harnesses trademark law to protect its brand. Read on as we explore how you can conquer the likelihood of confusion in your pharmaceutical trademarks.

Trademark 59

Trademark Branding Brands Branding 59

JD Supra Law

DECEMBER 23, 2021

With China's continuous investment in the pharmaceutical research and development industry and implementation of various incentive policies, various pharmaceutical transactions within PRC territory have been keeping active, among which pharmaceutical licensing transactions, especially cross-border pharmaceutical licensing transactions (License-in), (..)

Licensing 98

Licensing Marketing Marketing 98

IP Watchdog

OCTOBER 20, 2022

The People’s Vaccine Alliance, a coalition of over 100 organizations, issued a statement this week alleging that the pharmaceutical industry is attempting to tighten its control of the world’s pandemic response plans.

Reporting 81

Reporting IP Government Technology 81

IP Watchdog

FEBRUARY 8, 2024

Patents came up throughout the hearing as one barrier to lowering prescription drug prices, while pharmaceutical industry representatives underscored the cost of bringing innovative and life-saving drugs to market and the superior access Americans have to such drugs compared with other countries.

Marketing 59

Marketing Marketing Patent Business 59

IP Law 360

JANUARY 12, 2024

pharmaceutical industry promises new legal action. Florida's greenlight to import Canadian prescription drugs may spell legal trouble for the U.S. Food and Drug Administration as Ottawa prepares to counter anticipated supply and pricing issues and the U.S.

52

52

IP.com

DECEMBER 13, 2023

The impact of current inflation rates, the consolidation of organizations within the healthcare & pharmaceutical industries, and pharmaceutical price implications on U.S. government health programs such as Medicare and Medicaid have brought the Bayh-Dole Act back into the headlines of innovation industry news.

Intellectual Property Management 52

Intellectual Property Management Government Ownership Business 52

JD Supra Law

JANUARY 4, 2024

Sanofi decision may have on the biotech and pharmaceutical industries in 2024. In this episode of IP Talk with Wolf Greenfield, you’ll hear Wolf Greenfield attorneys from a variety of practice areas offering their insights on what to expect in the months ahead. Here are some of the highlights. By: Wolf, Greenfield & Sacks, P.C.

Intellectual Property Law 70

Intellectual Property Law Intellectual Property IP Business 70

JD Supra Law

MAY 12, 2023

on May 11, 2023, a case that could carry enormous implications for the pharmaceutical industry and patent litigation. The Supreme Court is expected to consider Teva’s pending petition for certiorari in the highly anticipated GlaxoSmithKline LLC v. Teva Pharms.

Litigation 98

Litigation Patent 98

Biswajit Sarkar Copyright Blog

MARCH 1, 2024

Biotechnological advancements have strong implications in the pharmaceutical and food industries as well as in genetic modifications in animals, microorganisms, and plants. Dairy and food industry: This industry has benefitted from new innovations and advancements in modern biotechnology.

Patent 92

Patent Inventor Invention Intellectual Property 92

IPilogue

FEBRUARY 2, 2022

I also had the pleasure of working with Cristina Aguirre, Privacy Officer at AstraZeneca, and learned about the day-to-day operations of a major pharmaceutical company from her perspective. As a multinational pharmaceutical company, AstraZeneca is often involved in complex patent litigation.

Business 106

Business Privacy Intellectual Property Law Advertising 106

IP Watchdog

JANUARY 19, 2023

Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) today jointly held an all-day listening session featuring speakers from patient advocacy and industry groups, academia, and brand and generic pharmaceutical companies who weighed in on the relationship between patents and affordable access to medicines.

Patent 128

Patent Branding Brands Branding 128

JD Supra Law

OCTOBER 6, 2023

The Federal Trade Commission (FTC) has released a new Policy Statement addressing one of its long-standing concerns in the pharmaceutical industry: the improper listing of patents in the Orange Book.

Patent 75

Patent 75

SpicyIP

MARCH 14, 2023

We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing the 4th edition of their workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 24-28, 2023. The last date to apply for the workshop is March 25, 2023.

Patent 121

Patent Editing Patent Application Art 121

IP Law 360

SEPTEMBER 28, 2023

A Delaware federal judge has found numerous patents covering Allergan's bowel treatment drug Viberzi were invalid, handing a win to Sun Pharmaceutical Industries Ltd. and MSN Pharmaceuticals.

Patent 45

Patent 45

IP Law 360

OCTOBER 17, 2023

Carlton Fields has hired a partner from Fox Rothschild LLP who focuses her practice on patent litigation with clients in the pharmaceutical, biotechnology, cannabis and psychedelic industries, the firm announced Tuesday.

Patent Law 52

Patent Law Law Patent Litigation 52

JD Supra Law

FEBRUARY 25, 2022

Teva Pharmaceuticals USA, Inc., This was the question facing the Federal Circuit in Adapt Pharma Operations Ltd. By: McDonnell Boehnen Hulbert & Berghoff LLP

Art 97

Art Patent 97

IP Watchdog

OCTOBER 24, 2022

Two major trade organizations representing global vaccine manufacturers are officially backing a proposal submitted to the G20 and G7 countries in July that they claim offers practical solutions for future pandemics to avoid the inequities that have been highlighted by the COVID-19 pandemic.

Technology 113

Technology Government Intellectual Property IP 113

JD Supra Law

OCTOBER 25, 2022

Evidence illustrates an uptick in arbitrations in the life sciences industry, with the International Chamber of Commerce reporting that health and pharmaceutical disputes have more than doubled between 2015 and 2020. Similarly, the American Arbitration Association saw a 40%. By: Allen & Overy LLP

Confidentiality 97

Confidentiality Reporting 97

McKinsey Operations

SEPTEMBER 20, 2022

Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals.

74

74

Corsearch

JULY 12, 2023

Uncover marketing authorization applications published by official authorities With the growing complexity of clearing pharmaceutical names – including PTO registers expanding with more marks, and regulatory requirements increasing – finding new names is increasingly challenging for pharma professionals.

Marketing 52

Marketing Marketing Trademark Branding 52

SpicyIP

MARCH 12, 2024

We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing a workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 26-30, 2024. The last date to apply for the workshop is March 24, 2024.

Patent 59

Patent Patent Application Art Editing 59

IP Law 360

MAY 5, 2023

A pair of Holland & Knight LLP intellectual property partners have joined Bradley Arant Bould Cummings LLP's office in Nashville, and Brown Rudnick LLP has brought on a former Paul Hastings LLP patent litigator with substantial experience in the pharmaceutical industry. Here are the details on these and other notable hires.

Intellectual Property 75

Intellectual Property IP Litigation Patent 75